Novel, nonpeptidic cyanamides as potent and reversible inhibitors of human cathepsins K and L.
about
Developing dual and specific inhibitors of dimethylarginine dimethylaminohydrolase-1 and nitric oxide synthase: toward a targeted polypharmacology to control nitric oxideCysteine proteases as therapeutic targets: does selectivity matter? A systematic review of calpain and cathepsin inhibitorsMechanistic insights into mode of action of novel natural cathepsin L inhibitors.Synthesis and biochemical evaluation of thiochromanone thiosemicarbazone analogues as inhibitors of cathepsin L.A highly potent and selective caspase 1 inhibitor that utilizes a key 3-cyanopropanoic acid moietyThe consequences of lysosomotropism on the design of selective cathepsin K inhibitors.Synthesis and biochemical evaluation of benzoylbenzophenone thiosemicarbazone analogues as potent and selective inhibitors of cathepsin L.Cathepsin K inhibitors increase distal femoral bone mineral density in rapidly growing rabbitsInhibitors of cathepsin C (dipeptidyl peptidase I).Discovery of novel cyanamide-based inhibitors of cathepsin C.Design, synthesis, and evaluation of inhibitors of cathepsin L: Exploiting a unique thiocarbazate chemotype.Inhibitory activity of Drynariae rhizoma extracts on cathepsin having bone resorption activity.Structure reassignment and synthesis of Jenamidines A1/A2, synthesis of (+)-NP25302, and formal synthesis of SB-311009 analogues.Advances in the discovery of cathepsin K inhibitors on bone resorption.Sulfonamide derivatives with protease inhibitory action as anticancer, anti-inflammatory and antiviral agents
P2860
Q24321779-448A7CE9-4FBD-4760-AEBE-533E8623CE7EQ26771736-7B91C4D0-650B-4EA8-97E5-EE010F039068Q30579667-D066387D-5ADC-4A13-81B3-F5AB16EC2E47Q33630596-4C9E5C54-A743-4DFE-8444-901A124D7D08Q34707912-415D7697-D469-4B59-ADD6-D5AF3754653FQ36572175-DEE35300-0969-421D-8381-65852D2B8756Q36775345-7E2576F7-DB42-4E6C-A00A-BD81E773DA98Q37427459-F8797C6F-A64B-4844-817C-EDEB99389778Q37703257-17C0E20F-9A13-4E96-9343-19327AE116CAQ39511897-9484BCE9-7A12-4556-8E20-26226E98606BQ41265835-4B7A45B1-24D1-4604-BE4D-442F00DABC76Q42167515-5BF0F347-D5C6-46F3-801A-FD89EA8F6EE5Q42425472-62B262A0-48B9-4614-9F7B-3D530756F5F1Q55645981-C3C31FE1-2784-4068-BC0B-050B086A4410Q58863308-1217AA5A-928F-4387-AF7E-2E6E1A7E8C78
P2860
Novel, nonpeptidic cyanamides as potent and reversible inhibitors of human cathepsins K and L.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
Novel, nonpeptidic cyanamides ...... s of human cathepsins K and L.
@ast
Novel, nonpeptidic cyanamides ...... s of human cathepsins K and L.
@en
type
label
Novel, nonpeptidic cyanamides ...... s of human cathepsins K and L.
@ast
Novel, nonpeptidic cyanamides ...... s of human cathepsins K and L.
@en
prefLabel
Novel, nonpeptidic cyanamides ...... s of human cathepsins K and L.
@ast
Novel, nonpeptidic cyanamides ...... s of human cathepsins K and L.
@en
P2093
P356
P1476
Novel, nonpeptidic cyanamides ...... s of human cathepsins K and L.
@en
P2093
Falgueyret JP
Percival MD
Riendeau D
Rydzewski RM
Wesolowski G
P304
P356
10.1021/JM0003440
P407
P577
2001-01-01T00:00:00Z